Oxbridge Re Holdings Equity Warrant (NASDAQ:OXBRW) — Market Cap & Net Worth
Market Cap & Net Worth: Oxbridge Re Holdings Equity Warrant (OXBRW)
Oxbridge Re Holdings Equity Warrant (NASDAQ:OXBRW) has a market capitalization of $574.50K ($574.50K) as of August 3, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #30857 globally and #6164 in its home market, demonstrating a -16.88% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Oxbridge Re Holdings Equity Warrant's stock price $0.12 by its total outstanding shares 5733590 (5.73 Million). See how much does Oxbridge Re Holdings Equity Warrant reinvest in capital to understand how much of operating cash flow is reinvested back into capital assets.
Oxbridge Re Holdings Equity Warrant Market Cap History: 2015 to 2026
Oxbridge Re Holdings Equity Warrant's market capitalization history from 2015 to 2026. Data shows change from $2.75 Million to $714.41K (-15.52% CAGR).
Oxbridge Re Holdings Equity Warrant Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Oxbridge Re Holdings Equity Warrant's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.44x
Oxbridge Re Holdings Equity Warrant's market cap is 0.44 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.86 Million | $19.06 Million | $2.58 Million | 0.10x | 0.72x |
| 2017 | $573.36K | $23.84 Million | -$20.59 Million | 0.02x | N/A |
| 2018 | $8.60K | $3.80 Million | -$7.75 Million | 0.00x | N/A |
| 2019 | $69.95K | $981.00K | -$150.00K | 0.07x | N/A |
| 2020 | $618.08K | $1.21 Million | $88.00K | 0.51x | 7.02x |
| 2021 | $3.38 Million | $10.22 Million | $8.66 Million | 0.33x | 0.39x |
| 2022 | $301.59K | $850.00K | -$1.75 Million | 0.35x | N/A |
| 2023 | $194.94K | $-7.05 Million | -$9.91 Million | -0.03x | N/A |
| 2024 | $2.75 Million | $546.00K | -$1.76 Million | 5.04x | N/A |
| 2025 | $1.14 Million | $2.58 Million | -$3.46 Million | 0.44x | N/A |
Competitor Companies of OXBRW by Market Capitalization
Companies near Oxbridge Re Holdings Equity Warrant in the global market cap rankings as of August 3, 2026.
Key companies related to Oxbridge Re Holdings Equity Warrant by market ranking:
- FINCANNA CAPITAL CORP. (F:4AL0): Ranked #30848 globally with a market cap of $582.22K USD ( €498.00K EUR).
- Faron Pharmaceuticals Oy (LSE:FARN): Ranked #30849 globally with a market cap of $582.06K USD ( GBX4.78 Billion GBX).
- MEDICOX Co. Ltd (KQ:054180): Ranked #30858 globally with a market cap of $573.12K USD ( ₩845.71 Million KRW).
- Ireka Corporation Bhd (KLSE:8834): Ranked #30859 globally with a market cap of $571.89K USD ( RM2.28 Million MYR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #30848 | FINCANNA CAPITAL CORP. | F:4AL0 | $582.22K | €0.00 |
| #30849 | Faron Pharmaceuticals Oy | LSE:FARN | $582.06K | GBX42.00 |
| #30858 | MEDICOX Co. Ltd | KQ:054180 | $573.12K | ₩153.00 |
| #30859 | Ireka Corporation Bhd | KLSE:8834 | $571.89K | RM0.01 |
Oxbridge Re Holdings Equity Warrant Historical Marketcap From 2015 to 2026
Between 2015 and today, Oxbridge Re Holdings Equity Warrant's market cap moved from $2.75 Million to $ 714.41K, with a yearly change of -15.52%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $714.41K | -37.39% |
| 2025 | $1.14 Million | -58.54% |
| 2024 | $2.75 Million | +1311.76% |
| 2023 | $194.94K | -35.36% |
| 2022 | $301.59K | -91.09% |
| 2021 | $3.38 Million | +447.59% |
| 2020 | $618.08K | +783.61% |
| 2019 | $69.95K | +713.33% |
| 2018 | $8.60K | -98.50% |
| 2017 | $573.36K | -69.23% |
| 2016 | $1.86 Million | -32.31% |
| 2015 | $2.75 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 2nd, 2026 the market cap of Oxbridge Re Holdings Equity Warrant was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $574.50K USD |
| MoneyControl | $574.50K USD |
| MarketWatch | $574.50K USD |
| marketcap.company | $574.50K USD |
| Reuters | $574.50K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Oxbridge Re Holdings Equity Warrant
Oxbridge Re Holdings Limited, through its subsidiaries, provides specialty property and casualty reinsurance solutions. The company underwrites collateralized reinsurance contracts primarily for property and casualty insurance companies in the Gulf Coast region of the United States. It also issues reinsurance contracts through digital securities by blockchain technology. It distributes its produc… Read more